RMD Open

Targeted proteomics identifies differentially expressed proteins in Sjögren's disease with incident lymphoma.

Imgenberg-Kreuz J, Fugmann C, Molin AM, ..., Nordmark G, Steering committee

RMD Open 11 (4) - [2025-10-23; online 2025-10-23]

Idiopathic inflammatory myopathies lack neutralising autoantibodies to type- I, II and III interferons.

Behere A, Mildner H, Peralta Garcia I, ..., Horuluoglu B, Landegren N

RMD Open 11 (3) - [2025-09-25; online 2025-09-25]

Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritis.

Turcinov S, Sharma RK, De Vries C, ..., Malmström V, Hensvold A

RMD Open 10 (4) - [2024-11-18; online 2024-11-18]

Genetic variants at the RTP4/MASP1 locus are associated with fatigue in Scandinavian patients with primary Sjögren's syndrome.

Norheim KB, Imgenberg-Kreuz J, Alexsson A, ..., Ronnblom L, Omdal R

RMD Open 7 (3) - [2021-12-00; online 2021-12-16]

Cigarette smoking patterns preceding primary Sjögren's syndrome.

Mofors J, Björk A, Richardsdotter Andersson E, ..., Alfredsson L, Wahren-Herlenius M

RMD Open 6 (3) - [2020-09-00; online 2020-10-01]

Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero.

Hedlund M, Thorlacius GE, Ivanchenko M, ..., Eloranta ML, Wahren-Herlenius M

RMD Open 6 (1) - [2020-01-00; online 2020-01-21]

Protein and DNA methylation-based scores as surrogate markers for interferon system activation in patients with primary Sjögren's syndrome.

Björk A, Richardsdotter Andersson E, Imgenberg-Kreuz J, ..., Nordmark G, Wahren-Herlenius M

RMD Open 6 (1) - [2020-01-00; online 2020-01-21]